https://pubchem.ncbi.nlm.nih.gov/compound/Satralizumab
Satralizumab - PubChem
Satralizumab chemical information summary.
satralizumabpubchem
https://pubmed.ncbi.nlm.nih.gov/41744011/
Comparative analysis of adverse event reporting signals between Satralizumab and Inebilizumab in...
Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disorder predominantly driven by anti-aquaporin-4 immunoglobulin G (AQP4-IgG), which...
adverse event reportingcomparative analysis
https://adisinsight.springer.com/drugsafety/803924833?error=cookies_not_supported&code=3b21c9e6-0d7a-48e0-ae12-c0209b112cc3
Satralizumab-related AEs identified in FAERS - AdisInsight
Satralizumab therapy is associated with increased risks of infections, according to findings of a study published in the Journal of Neurology.Disproportionality
satralizumabrelatedaesidentifiedfaers